Restless Legs Syndrome Trial, Recruiting NCT05695963 Sponsor: University Hospital, Bordeaux Condition: Restless Legs Syndrome
Back to Restless Legs Syndrome

Restless Legs Syndrome Trial, Recruiting

NCT05695963
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old
  • You have been diagnosed with restless legs syndrome (RLS) that has no known underlying cause, confirmed by your medical history and meeting 5 specific RLS diagnostic criteria
  • Your general physical examination results are normal
  • You are covered by a social security or health insurance scheme
  • You are willing and able to give your free, informed, written consent to participate before the study begins

Who may not be able to join:

  • You have a significant mental health condition such as schizophrenia, bipolar disorder, severe depression, dementia, OCD, ADHD, or a mood disorder
  • You have a history of, or currently experience, chronic pain unrelated to RLS, epilepsy, a serious head injury, nerve damage (peripheral neuropathy), or diabetes
  • You have clinically significant sleep apnea, narcolepsy, or your RLS is caused by another condition such as kidney failure, dialysis, or pregnancy
  • You have another serious or unstable health condition — such as a heart condition or cancer — that could affect your participation or the study results
  • You are currently pregnant or breastfeeding
  • You are someone who is legally restricted from participating in research, such as a person deprived of liberty, a minor, or someone who lacks the legal capacity to give consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Imad Marc Antoine GHORAYEB, MD, PhD, University Hospital, Bordeaux

Phone: (0)5.56.79.55.13

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 January 2024
Est. completion
1 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Feasibility of Ecological Momentary Assessment (EMA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov